StonvexLoading…
StonvexStonvexStonvexCore line items from VENU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.90M | $17.90M | $13.37M | $7.99M |
Operating Income | $-11.49M | $-46.13M | $-38.82M | $-28.85M |
Net Income | $-13.76M | $-44.09M | $-35.84M | $-12.30M |
EPS (Diluted) | $-0.29 | $-1.10 | $-0.91 | $-0.77 |
Total Assets | $461.35M | $370.56M | $314.81M | $242.05M |
Total Liabilities | $186.33M | $171.70M | $108.36M | $68.08M |
Cash & Equivalents | $56.60M | $41.31M | $58.18M | $37.43M |
Free Cash Flow OCF − CapEx | $-74.38M | $-134.01M | $-81.61M | $-48.70M |
Shares Outstanding | 57.26M | 42.86M | 43.25M | 40.08M |